Is eHealth, Inc. overvalued or undervalued?

As of 7 May 2025, the valuation grade for eHealth, Inc. has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently undervalued, with a P/E ratio of 6, a Price to Book Value of 0.20, and an EV to EBITDA ratio of 0.40, which are all substantially lower than industry averages.
In comparison to its peers, eHealth, Inc. has a much more favorable PEG ratio of 0.02, while Clover Health Investments Corp. and Abacus Life, Inc. are both classified as risky with negative P/E ratios of -61.11 and -41.77, respectively. This stark contrast highlights eHealth's potential for growth and value. Despite recent underperformance against the S&P 500, where eHealth has seen a year-to-date decline of 57.55% compared to a 2.44% gain for the index, the current valuation metrics suggest that eHealth, Inc. presents a compelling investment opportunity.